nialamide has been researched along with Hepatic Encephalopathy in 2 studies
Nialamide: An MAO inhibitor that is used as an antidepressive agent.
Hepatic Encephalopathy: A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
ALBORNOZ-PLATA, A | 1 |
MAGNENAT, P | 1 |
OTT, T | 1 |
FREI, J | 1 |
DELALOYE, B | 1 |
KLAUS, E | 1 |
2 other studies available for nialamide and Hepatic Encephalopathy
Article | Year |
---|---|
[Nialamide in gastroenterology. Its possible use in hepatic coma].
Topics: Gastroenterology; Hepatic Encephalopathy; Humans; Iproniazid; Nialamide | 1961 |
[Study of Niamid in hepatic encephalopathy].
Topics: Hepatic Encephalopathy; Humans; Liver Cirrhosis; Monoamine Oxidase Inhibitors; Nialamide; Organic Ch | 1962 |